Short description
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Description
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Basel, Basel-Stadt, Switzerland, Europe
Founded on
January 1, 2018
Exited on
June 23, 2021
Went public on
June 23, 2021
Stock symbol
GLUE
Non-profit?
No
Acquired?
No
Employees count
51-100
Investors
Uh Ohhhh, No Way, No Way, Cannot Access, No Way, No Way, Uh Ohhhh, Noway Youcantaccess, Cannot Access, Noaccessforu, Nopepepe, Blurry Noaccess, Cannot Access, Blurry Noaccess
Sign in for full access
Founders
Alexander Flohr